These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36084974)

  • 1. Pediatric Mineral and Bone Disorder of Chronic Kidney Disease and Cardiovascular Disease.
    Kusumi K; Kremsdorf R; Kakajiwala A; Mahan JD
    Adv Chronic Kidney Dis; 2022 May; 29(3):275-282. PubMed ID: 36084974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral metabolism and cardiovascular disease in CKD.
    Fujii H; Joki N
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):53-63. PubMed ID: 28062938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
    Iwashita Y; Iwashita Y; Ito T; Shigematsu T
    Clin Calcium; 2016 Feb; 26(2):259-67. PubMed ID: 26813506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease.
    Staude H; Jeske S; Schmitz K; Warncke G; Fischer DC
    Kidney Blood Press Res; 2013; 37(1):68-83. PubMed ID: 23548827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD).
    Hruska KA; Choi ET; Memon I; Davis TK; Mathew S
    Pediatr Nephrol; 2010 Apr; 25(4):769-78. PubMed ID: 19898875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
    Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
    Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of bone in CKD-mediated mineral and vascular disease.
    Khouzam NM; Wesseling-Perry K; Salusky IB
    Pediatr Nephrol; 2015 Sep; 30(9):1379-88. PubMed ID: 25168424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.
    Brandenburg VM; D'Haese P; Deck A; Mekahli D; Meijers B; Neven E; Evenepoel P
    Pediatr Nephrol; 2016 Feb; 31(2):195-206. PubMed ID: 25735207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease.
    Khouzam N; Wesseling-Perry K
    Pediatr Nephrol; 2019 Jan; 34(1):1-10. PubMed ID: 28939921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the burden of cardiovascular disease in children with chronic kidney disease: prevention vs. damage limitation.
    Shroff R
    Pediatr Nephrol; 2021 Aug; 36(8):2537-2544. PubMed ID: 34143301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommendations for mineral and bone disorder in chronic kidney disease].
    Staszków M; Przedlacki J
    Wiad Lek; 2014; 67(3):422-5. PubMed ID: 25782204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
    Omata M; Fukagawa M; Kakuta T
    Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha is associated with mineral bone disorder and growth impairment in children with chronic kidney disease.
    Meza K; Biswas S; Zhu YS; Gajjar A; Perelstein E; Kumar J; Akchurin O
    Pediatr Nephrol; 2021 Jun; 36(6):1579-1587. PubMed ID: 33387018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications.
    Salanova Villanueva L; Sánchez González C; Sánchez Tomero JA; Aguilera A; Ortega Junco E
    Nefrologia; 2016; 36(4):368-75. PubMed ID: 27118192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of the chronic kidney disease-mineral bone disorder.
    Hruska KA; Seifert M; Sugatani T
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):303-9. PubMed ID: 26050115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology.
    Hruska KA; Sugatani T; Agapova O; Fang Y
    Bone; 2017 Jul; 100():80-86. PubMed ID: 28119179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
    Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
    Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease-mineral-bone disorder: a new paradigm.
    Moe SM; Drüeke T; Lameire N; Eknoyan G
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):3-12. PubMed ID: 17200038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
    Hsu CY; Chen LR; Chen KH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder.
    Hanudel MR; Salusky IB
    Curr Osteoporos Rep; 2017 Jun; 15(3):198-206. PubMed ID: 28455644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.